Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Larimar Therapeutics Inc’s stock clocked out at $3.46, down -3.35% from its previous closing price of $3.58. In other words, the price has decreased by -$3.35 from its previous closing price. On the day, 0.57 million shares were traded. LRMR stock price reached its highest trading level at $3.59 during the session, while it also had its lowest trading level at $3.36.
Ratios:
To gain a deeper understanding of LRMR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.10 and its Current Ratio is at 13.10. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on October 16, 2024, initiated with a Outperform rating and assigned the stock a target price of $26.
On October 03, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $22.
On October 02, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $15.H.C. Wainwright initiated its Buy rating on October 02, 2024, with a $15 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 16 ’24 when Hamilton Thomas Edward bought 57,208 shares for $8.74 per share. The transaction valued at 499,998 led to the insider holds 564,798 shares of the business.
Flynn James E bought 4,290,617 shares of LRMR for $37,499,993 on Feb 16 ’24. The Director now owns 6,151,406 shares after completing the transaction at $8.74 per share. On Feb 14 ’24, another insider, THOMAS FRANK E, who serves as the Director of the company, bought 2,000 shares for $11.00 each. As a result, the insider paid 22,000 and bolstered with 2,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LRMR now has a Market Capitalization of 220770832 and an Enterprise Value of 30082728.
Stock Price History:
The Beta on a monthly basis for LRMR is 0.90, which has changed by -0.38803416 over the last 52 weeks, in comparison to a change of 0.23883796 over the same period for the S&P500. Over the past 52 weeks, LRMR has reached a high of $13.68, while it has fallen to a 52-week low of $3.01. The 50-Day Moving Average of the stock is -31.68%, while the 200-Day Moving Average is calculated to be -51.46%.
Shares Statistics:
It appears that LRMR traded 809.80K shares on average per day over the past three months and 487940 shares per day over the past ten days. A total of 63.81M shares are outstanding, with a floating share count of 37.01M. Insiders hold about 42.00% of the company’s shares, while institutions hold 60.96% stake in the company. Shares short for LRMR as of 1735603200 were 5070190 with a Short Ratio of 6.26, compared to 1732838400 on 3877818. Therefore, it implies a Short% of Shares Outstanding of 5070190 and a Short% of Float of 12.1700004.